Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin (Q44151319)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2002

Language	Label	Description	Also known as
English	Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin	scientific article published in August 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael R Jacobs

5

object named as

Michael R Jacobs

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Frederick A Browne

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Cathy Clark

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bülent Bozdogan

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bonifacio E Dewasse

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Peter C Appelbaum

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

93-99

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary targets of fluoroquinolones in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent antipneumococcal activity of gemifloxacin is associated with dual targeting of gyrase and topoisomerase IV, an in vivo target preference for gyrase, and enhanced stabilization of cleavable complexes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipneumococcal activities of gemifloxacin compared to those of nine other agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular epidemiology of Streptococcus pneumoniae with decreased susceptibility to penicillin in a Paris children's hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900120-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(02)00120-6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44151319&oldid=2288165303"